Keros Therapeutics said on Thursday it had paused giving patients higher doses of its high blood pressure treatment in a mid-stage study after reports of a safety issue, sending its shares plunging 77%.
The CRISPR pioneer Editas Medicine announced layoffs and abandoned its lead sickle-cell program.
The efficacy data could help cushion Ibrance’s losses of market share to Kisqali, a similar drug from Novartis.
The U.S. last year hit a grim milestone: the most pediatric flu deaths since before the pandemic.
Fox News senior medical analyst Dr. Marc Siegel and Fox News correspondent Alexandria Hoff discuss the FDA and the health risks of ultra-processed foods on…
December 13, 2024, 12:00 pm – 2:00 pm Location: TBD Speaker: Virginia Caine, MD, 125th President of the National Medical Association Topic: “Innovations in Reducing…
Toronto Maple Leafs goaltender Anthony Stolarz will not return to Thur…
The CRISPR pioneer Editas Medicine announced layoffs and abandoned its lead sickle-cell program.
The design of the gun police say they found on the alleged United Healthcare CEO’s killer—the FMDA or “Free Men Don’t Ask”—was released by a…
An AI version of old St. Nick arrives as a seasonal character in popular chatbot app.
